Quick Answer
HEALTHSTREAM INC reported R&D Expense of $50.98 million for fiscal year 2025.
HEALTHSTREAM INC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $50.98M | +4.3% |
| 2024 | $48.89M | +7.4% |
| 2023 | $45.54M | +2.9% |
| 2022 | $44.28M | +6.3% |
| 2021 | $41.66M | +29.0% |
| 2020 | $32.30M | +11.0% |
| 2019 | $29.11M | +13.1% |
| 2018 | $25.73M | +6.6% |
| 2017 | $24.15M | -0.4% |
| 2016 | $24.23M | +0.1% |
| 2015 | $24.21M | +47.1% |
| 2014 | $16.46M | +40.0% |
| 2013 | $11.76M | +36.6% |
| 2012 | $8.61M | +15.2% |
| 2011 | $7.47M | +6.9% |
| 2010 | $6.99M | +11.2% |
| 2009 | $6.29M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $12.11M | +0.1% | +0.3% |
| June 30, 2025 | $12.07M | -0.0% | +0.2% |
| March 31, 2025 | $12.05M | +0.1% | -0.4% |
| September 30, 2024 | $12.10M | +11.0% | +0.2% |
| June 30, 2024 | $12.08M | +9.5% | +0.4% |
| March 31, 2024 | $12.03M | +3.0% | +10.4% |
| September 30, 2023 | $10.90M | -5.0% | -1.2% |
| June 30, 2023 | $11.03M | +4.2% | -5.6% |
- HEALTHSTREAM INC showed an increase of +4.3% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2025 period, HEALTHSTREAM INC’s r&d expense has grown by 711.2% (from $6.29 million to $50.98 million).
- The most recent figure is from HEALTHSTREAM INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: